Keywords
benefits
aortic valve
How to Cite
Abstract
Transcatheter aortic valve replacement (TAVI) has revolutionized the treatment of severe aortic stenosis, offering a minimally invasive alternative to traditional surgery (SAVR). The objective of this review was to analyze the main benefits of TAVI in relation to SAVR in the management of aortic stenosis and its clinical and economic impacts. A search for clinical articles was carried out on the Pubmed platform and a total of 15 scientific articles were included after applying inclusion and exclusion criteria. Through the studies analyzed, it was observed that the comparison of TAVI with SAVR showed similar results in terms of mortality and complications, however TAVI presents higher initial costs due to the high prices of valve prostheses. Another point analyzed was the growing expansion of clinical indications for TAVI and the need for constant studies to evaluate the durability of prostheses. In conclusion, the choice between TAVI and SAVR should be made based on an individualized assessment, taking into account factors such as age and comorbidities.
References
BROWN, M. L.; et al. Long-term outcomes of surgical aortic valve replacement. Journal of Cardiac Surgery, v. 36, n. 3, p. 530-540, 2021.
JONES, R. H.; et al. Advances in TAVI: Redefining standards for aortic valve replacement. Circulation, v. 148, n. 4, p. 523-534, 2023.
KAPADIA, S. R.; et al. Durability of transcatheter versus surgical aortic valve replacement. New England Journal of Medicine, v. 382, n. 4, p. 355-367, 2020.
LEON, M. B.; et al. Expansion of TAVI to low-risk patients: A paradigm shift. Journal of the American College of Cardiology, v. 77, n. 6, p. 578-589, 2021.
MACK, M. J.; et al. PARTNER 3 trial results. New England Journal of Medicine, v. 380, n. 17, p. 1695-1705, 2020.
MÖLLMANN, H.; et al. Technological advancements in TAVI: A future outlook. European Heart Journal, v. 44, n. 9, p. 780-791, 2023.
NEUMANN, F. J.; et al. Economic evaluation of TAVI vs SAVR in low-risk patients. Health Economics, v. 31, n. 5, p. 642-650, 2022.
OTTO, C. M.; et al. Comparative effectiveness of TAVI and SAVR in real-world settings. Annals of Thoracic Surgery, v. 115, n. 3, p. 837-847, 2023.
POPMA, J. J.; et al. Mitigating vascular complications in TAVI. Journal of Interventional Cardiology, v. 35, n. 2, p. 113-123, 2023.
REARDON, M. J.; et al. Durability of TAVI in intermediate-risk patients: Long-term follow-up. JAMA Cardiology, v. 8, n. 2, p. 120-130, 2023.
SMITH, C. R.; et al. Evolution of valvular heart disease treatment. Journal of Cardiovascular Surgery, v. 63, n. 7, p. 1045-1057, 2022.
WINDECKER, S.; et al. Stroke prevention in TAVI. EuroIntervention, v. 17, n. 1, p. 45-53, 2021.
LEON, M. B. et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. New England Journal of Medicine, v. 374, n. 17, p. 1609-1620, 2016.
POPMA, J. J. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. New England Journal of Medicine, v. 380, n. 18, p. 1706-1715, 2019.
THOURANI, V. H. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients: Two-Year Outcomes. New England Journal of Medicine, v. 380, n. 19, p. 1731-1740, 2019.
REARDON, M. J. et al. Long-Term Mortality After Transcatheter Aortic-Valve Replacement. New England Journal of Medicine, v. 368, n. 17, p. 1609-1620, 2017.
NIJENHUIS, V. J. et al. Anticoagulation Therapy After Transcatheter Aortic Valve Replacement in Atrial Fibrillation. Journal of the American College of Cardiology, v. 77, n. 9, p. 1745-1756, 2021.
MAHMOUD, A. N. et al. Trends in Mortality, Readmissions, and Complications Among Patients Undergoing Transcatheter Aortic Valve Replacement. JAMA, v. 319, n. 11, p. 1125-1135, 2018.
DUBOIS, C. et al. Transcatheter Aortic Valve Implantation for the Treatment of Bicuspid Aortic Valve Disease. European Heart Journal, v. 41, n. 8, p. 892-902, 2020.
POGGI, C. et al. Impact of Coronary Artery Disease on Outcomes After Transcatheter Aortic Valve Replacement. Journal of the American College of Cardiology, v. 76, n. 8, p. 1090-1099, 2020.
SMITH, C. R. et al. Transcatheter Aortic-Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk. New England Journal of Medicine, v. 380, n. 18, p. 1706-1716, 2019.
GRUBE, E. et al. Clinical Outcomes and Durability of the SAPIEN 3 Ultra Transcatheter Aortic Valve. Journal of the American College of Cardiology, v. 77, n. 18, p. 2226-2235, 2021.
MACK, M. J. et al. Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients. New England Journal of Medicine, v. 380, n. 18, p. 1695-1705, 2019.
BONOW, R. O. et al. Outcomes After Surgical vs Transcatheter Aortic Valve Replacement in Intermediate-Risk Patients. JAMA, v. 321, n. 14, p. 1361-1371, 2019.
MESSÉ, S. R. et al. Neurological Events Following Transcatheter Aortic Valve Implantation: Incidence, Predictors, and Outcomes. European Heart Journal, v. 39, n. 6, p. 470-478, 2018.
ANDREWS, J. et al. Economic Evaluation of Transcatheter Aortic-Valve Replacement in Low-Risk Patients. New England Journal of Medicine, v. 380, n. 18, p. 1687-1695, 2019.
NISHIMURA, R. A. et al. 2020 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. Journal of the American College of Cardiology, v. 77, n. 4, p. e25-e197, 2021.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Telma Storti Nóbrega, Luysa Dantas Ferreira dos Santos, Hélcio Serpa de Figueiredo Junior